Idioma:

COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)

Sem texto completo

Citações Citado por

Título:
COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)
Assuntos: Clinical Medicine and Science ; clinical trial ; dementia ; geriatrics ; parkinson disease
Notas: http://dx.doi.org/10.13039/501100000925
Descrição: A/Pr Rosie Watson | Many people who have been diagnosed with dementia with Lewy bodies or Parkinson’s disease dementia will be prescribed drugs known as acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine) to help with their symptoms. This research trial, known as COBALT, is designed to find out whether there is any benefit from taking the drug memantine as well. Australian and UK researchers are collaborating on this trial which will recruit eligible participants from both countries. | $1,218,120 | International Collaborations | NHMRC-NIHR Collaborative Research Grants - 2019 Round 1
Data de criação/publicação: 2026
Idioma: Inglês

Links

Voltar para lista de resultados

Buscando em bases de dados remotas. Favor aguardar.